HER2-ultralow Breast Cancer: Incidence, Clinicopathologic Features and Need for Refined Scoring System. Morrar D, Brogi E, Schwartz CJ, Pareja F, et al. Mod Pathol 2025 Sep 29:100901. doi: 10.1016/j.modpat.2025.100901.

Read + Share

Amedeo Smart

Independent Medical Education

Morrar D, Brogi E, Schwartz CJ, Pareja F, et al. HER2-ultralow Breast Cancer: Incidence, Clinicopathologic Features and Need for Refined Scoring System. Mod Pathol 2025 Sep 29:100901. doi: 10.1016/j.modpat.2025.100901.
PMID: 41033579